Hamill Laura - Insider Non-Derivative Transactions at Y-mAbs Therapeutics, Inc. (YMAB) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 11, 2024, Hamill Laura's relationship to Y-mAbs Therapeutics, Inc. (YMAB) is Director, and currently has 5,825 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other YMAB insiders.
Data Source: SEC.
Hamill Laura - Insider Non-Derivative Transactions of YMAB Common Stock
Hamill Laura - Insider Non-Derivative Transactions at YMAB
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 12, 2024 | Acquisition -- (Common Stock) | 3495 | 0 | 5825 |
| Jun 9, 2023 | Acquisition -- (Common Stock) | 2330 | 0 | 2330 |